Related Tags >> FDA pharmaceuticals Phase III Regulators

Drug Safety News

Most Popular Drug Safety Story

Aastrom shares jump as FDA lifts clinical hold

June 18, 2009 — 10:30am ET | By Maureen Martino

Aastrom's shares are up on the news that the FDA has lifted a clinical hold on the company's Phase II congestive heart failure trial. The trial is testing cardiac repair cells (CRC), which contain... Read more...

Drug Safety Press Releases

FDA Issues Safety Communication about an Ongoing Review of Stimulant Medications Used in Children with ADHD
HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition
New Publication Shows CleviprexTM Provides More Precise Blood Pressure Control in Cardiac Surgery Patients
Pfizer Launches New Medicine Safety Website to Help Healthcare Professionals and Patients Make Better Informed Decisions about T

Latest Headlines

Aastrom shares jump as FDA lifts clinical hold
June 18, 2009
Doctor demands halt to FDA review of Lilly's prasugrel
June 3, 2009
FDA nominee sees need for confidence boost
May 7, 2009
Infant's death raises questions about overseas trials
March 23, 2009
Booming biz raises questions about vax legal shield
February 23, 2009
Prasugrel vote will signal FDA's risk/benefit stance
February 2, 2009
FDA study: More women in clinical trials
November 25, 2008
Sanofi discontinues clinical trials for Acomplia
November 5, 2008
ZymoGenetics shares plunge after risks halt trial
October 28, 2008
Savient shares crater on adverse events
October 27, 2008
FDA considers new trial standard for diabetes drugs
June 24, 2008
Gentium shares slide on safety board concerns
June 6, 2008
ALSO NOTED: FDA, Medicare team up on drug surveillance; Early stage prostate vaccine shows promise; and much more...
May 23, 2008
1,300 new hires planned for FDA expansion
May 1, 2008
ALSO NOTED: Isotechnika reports psoriasis success; Romark enrolls hep C patients; and much more...
April 18, 2008
Wyeth, ViroPharma drops Hep C drug
April 17, 2008
Stem cell developers shift focus to FDA hearings
April 10, 2008
ALSO NOTED: Crucell shares up on TB data; Celera, Merck ink cancer deal; and much more...
April 10, 2008
Canada's streamlined approval process raises protests
April 9, 2008
Eschenbach offers 'Andy's Take' on FDA issues
April 4, 2008

Paid Research Reports

More Research Reports >>